| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 04/27/2000 | WO1999063933A9 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 04/27/2000 | CA2749553A1 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 04/27/2000 | CA2348156A1 Human proteins involved in endoplasmic reticulum protein degradation |
| 04/27/2000 | CA2348022A1 Condensed pyridazine derivatives, their production and use |
| 04/27/2000 | CA2347080A1 Tnfr related gene 12 |
| 04/27/2000 | CA2346937A1 Specific therapeutic interventions obtained by interference with redistribution and/or targeting |
| 04/27/2000 | CA2346656A1 Methods of hydrating mucosal surfaces |
| 04/26/2000 | EP0995751A2 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction |
| 04/26/2000 | EP0995750A1 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction |
| 04/26/2000 | EP0994876A1 Quaternary ammonium compounds as tachykinin antagonists |
| 04/26/2000 | EP0994870A1 Novel aryloxy substituted pyrimidine imidazole compounds |
| 04/26/2000 | EP0994867A1 Polymorphic form of the tachykinin receptor antagonist 2-(r)-(1-(r) -(3,5-bis(trifluoromethyl) phenyl)ethoxy)-3-(s)-(4-fluoro) phenyl-4-(3-5 (-oxo-1h,4h-1,2,4,-triazolo) methylmorpholine |
| 04/26/2000 | EP0994861A1 NEW $g(b)-AMINO AND $g(b)-AZIDOCARBOXYLIC ACID DERIVATIVES, THE PRODUCTION THEREOF AND THE USE THEREOF AS ENDOTHELIN RECEPTOR ANTAGONISTS |
| 04/26/2000 | EP0994853A2 Compounds and methods for the inhibition of the expression of vcam-1 |
| 04/26/2000 | EP0738269B1 Piperidine derivatives with paf antagonist activity |
| 04/26/2000 | EP0736020B1 6-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists |
| 04/26/2000 | EP0670826B1 Fatty acid derivatives and pharmaceutical compositions containing them |
| 04/26/2000 | EP0554381B2 Use of protective agents against reactive oxygen species |
| 04/26/2000 | CN1251579A Compound and compositions for treating diseases associated with serine protease, particularly tryptase, activity |
| 04/26/2000 | CN1051705C Composition comprising tramadol material and any of codeine, oxycodone or hydrocodone and their use thereof |
| 04/25/2000 | US6054593 Elastase inhibitor |
| 04/25/2000 | US6054560 Mitogen activated protein kinase, FRK |
| 04/25/2000 | US6054559 Interleukin-1 receptor antagonist beta (IL-1raβ) |
| 04/25/2000 | US6054486 Use of 9-Deoxy-2',9-α-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen e)-13,14-dihydro-prostaglandin f1 to treat peripheral vascular disease |
| 04/25/2000 | US6054475 Substituted dihydrobenzofuran-based phosphodiesterase 4 inhibitors useful for treating airway disorders |
| 04/25/2000 | US6054463 Methods for treating dermatitis using descarboethoxyloratadine |
| 04/25/2000 | US6054460 Anticonvulsive and antiallergic/antiasthmatic pyrazolo-[3,4-d]pyrimidines, and process for preparing |
| 04/25/2000 | US6054446 17-substituted-17-desoxy-1,3,5-estratrienes. |
| 04/25/2000 | US6054434 8a-azalides as veterinary antimicrobal agents |
| 04/25/2000 | US6054143 Xylitol delivery |
| 04/25/2000 | US6054130 Non-splicing variants of gp350/220 |
| 04/25/2000 | CA2105575C Esters of bi- and tricyclic amino alcohols, their preparation and their use in pharmaceutical compositions |
| 04/23/2000 | CA2287562A1 Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction |
| 04/22/2000 | CA2285749A1 Novel proteins from actinobacillus pleuropneumoniae |
| 04/20/2000 | WO2000022143A2 Protein kinase homologs |
| 04/20/2000 | WO2000022113A1 ENZYMATIC SYNTHESIS OF ssDNA |
| 04/20/2000 | WO2000021963A1 Il-8 receptor antagonists |
| 04/20/2000 | WO2000021961A1 Imidazo-isoquinoline compounds, their compositions and uses |
| 04/20/2000 | WO2000021947A1 Benzazine derivatives as phosphodiesterase 4 inhibitors |
| 04/20/2000 | WO2000021931A1 Ureidopiperidine derivatives as selective human nk3 receptor antagonists |
| 04/20/2000 | WO2000021564A1 Composition and method for treating allergic diseases |
| 04/20/2000 | WO2000021525A2 Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent |
| 04/20/2000 | WO2000021514A2 Method and composition for treating and preventing tuberculosis |
| 04/20/2000 | WO2000021512A2 Composition and method for treating allergic diseases |
| 04/20/2000 | WO2000021510A2 Formulations of fexofenadine |
| 04/20/2000 | WO2000021509A2 Methods of treatment |
| 04/20/2000 | WO2000021487A2 Formoterol polymorphs |
| 04/20/2000 | WO1999066917A3 Composition comprising ss-hydroxy-ss-methylbutyric acid and at least one amino acid |
| 04/20/2000 | WO1999066037A3 Antisense oligonucleotides for treating or preventing atopic diseases and neoplastic cell proliferation |
| 04/20/2000 | WO1999065571A3 Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders |
| 04/20/2000 | WO1999064000A9 Novel therapeutic agents that modulate neurokinin receptors |
| 04/20/2000 | DE19847969A1 Stable liquid formulation of formoterol in solution or suspension medium, used after dilution for treatment of asthma by inhalation |
| 04/20/2000 | DE19847968A1 Separate storage of an active material and a solvent comprises a closure cap and a container, with a chamber attached to the unit. |
| 04/20/2000 | CA2346813A1 Method and composition for treating and preventing tuberculosis |
| 04/20/2000 | CA2346775A1 Protein kinase homologs |
| 04/20/2000 | CA2346729A1 Ureidopiperidine derivatives as selective human nk3 receptor antagonists |
| 04/20/2000 | CA2346414A1 Imidazo-isoquinoline compounds, their compositions and uses |
| 04/20/2000 | CA2346307A1 Formulations of fexofenadine |
| 04/20/2000 | CA2346228A1 Composition and method for treating allergic diseases |
| 04/20/2000 | CA2346227A1 Composition and method for treating allergic diseases |
| 04/20/2000 | CA2346155A1 Enzymatic synthesis of ssdna |
| 04/20/2000 | CA2344694A1 Benzazine derivatives as phosphodiesterase 4 inhibitors |
| 04/19/2000 | EP0994113A2 7-Aminopyrido(2,3-d)-pyrimidine derivatives for treatment of bronchial asthma |
| 04/19/2000 | EP0993457A1 Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists |
| 04/19/2000 | EP0993449A1 Quinoline derivatives as pde iv and/or tnf inhibitors |
| 04/19/2000 | EP0880524B1 Adenosin antagonists, method of preparing them and their use as drugs |
| 04/19/2000 | EP0738262B1 Novel heterocyclic compounds |
| 04/19/2000 | CN1251133A Bi or multifunctional molecules based on dendroaspin scaffold |
| 04/19/2000 | CN1251039A Antitussive compositions |
| 04/19/2000 | CN1251038A IL-8 receptor antagonists |
| 04/19/2000 | CN1250776A Heterodicyclic compound derivatives |
| 04/19/2000 | CN1250668A Stable protein compositions |
| 04/19/2000 | CN1250664A Chinese medicine for treating gout |
| 04/19/2000 | CN1250660A Liquid medicine for treating wound and pain |
| 04/19/2000 | CN1051548C Heterobicyclic derivatives, pharmaceutical compositions contg. same, mfg. method and use thereof |
| 04/18/2000 | US6051718 A phosphodiesterase enzyme inhibitor and a cytokine antagonist for treating allergic, atopic and inflammatory diseases inflammatory diseases |
| 04/18/2000 | US6051601 Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene B4 (LTB4) antagonists |
| 04/18/2000 | US6051583 2,3,3a,4,9,9a-hexahydro-8-hydroxy-1H-benz[f]indoles, processes for preparing them and their use as pharmaceutical compositions |
| 04/18/2000 | US6051580 Neurokinin antagonist; antiasthma agent |
| 04/18/2000 | US6051566 Anti-reactive anti-asthmatic activity of non-steroidal anti-inflammatory drugs by inhalation |
| 04/18/2000 | US6051224 Compositions and methods for targeting cells and modulating pulmonary surfactant secretion |
| 04/13/2000 | WO2000020635A1 ANTISENSE MODULATION OF INTEGRIN α4 EXPRESSION |
| 04/13/2000 | WO2000020430A1 Crystal of diuridine tetraphosphate or salt thereof and method for preparing the same, and method for producing said compound |
| 04/13/2000 | WO2000020402A1 Chemical compounds |
| 04/13/2000 | WO2000020401A1 New bis-benzimidazoles |
| 04/13/2000 | WO2000020398A1 Biphenylene lactams as prostaglandin receptor ligands |
| 04/13/2000 | WO2000020395A1 New crystal modification iii of torasemide |
| 04/13/2000 | WO2000020394A1 Benzamide derivatives as thrombin inhibitors |
| 04/13/2000 | WO2000020391A1 2,3-disubstituted pyridine derivatives, process for the preparation thereof, drug compositions containing the same and intermediates for the preparation |
| 04/13/2000 | WO2000020389A1 Naphthalenecarboxamides as tachykinin receptor antagonists |
| 04/13/2000 | WO2000020382A1 Energetic nitramine-linked azoles and hydroxylammonium salts as oxidizers, initiators and gas generators |
| 04/13/2000 | WO2000020371A1 Prostaglandin receptor ligands |
| 04/13/2000 | WO2000020370A1 2, 4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors |
| 04/13/2000 | WO2000020039A1 Methods and adjuvants for stimulating mucosal immunity |
| 04/13/2000 | WO2000020003A1 Naphthalenecarboxamides as tachykinin receptor antagonists |
| 04/13/2000 | WO2000019988A1 NOVEL Th2-SPECIFIC MOLECULES AND USES THEREOF |
| 04/13/2000 | WO2000019984A2 Coated medicament forms with controlled active substance release |
| 04/13/2000 | WO2000002877A3 New pharmaceutically active compounds |
| 04/13/2000 | WO2000002850A3 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators |
| 04/13/2000 | CA2346496A1 Novel th2-specific molecules and uses thereof |